Trial intelligence / Profile preview

Triesence for visualization during vitrectomy

NCT00532415Phase 3Completed

Sponsor
Alcon Inc.
Start
Sep 2007
Primary completion
Sep 2007
Modality
Orthosteric Ligands
01

Overview

A Phase 3 trial of triamcinolone acetonide in vitrectomy, sponsored by Alcon Inc.. Started Sep 2007; status: completed.

02

Drugs

triamcinolone acetonide
03

Conditions

vitrectomy

Beyond the preview

Go deeper on NCT00532415.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00532415.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call